Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.

Smits KM, Smits LJ, Peeters FP, Schouten JS, Janssen RG, Smeets HJ, van Os J, Prins MH.

Psychiatr Genet. 2008 Aug;18(4):184-90. doi: 10.1097/YPG.0b013e3283050aca.

PMID:
18628680
2.

Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.

Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH.

Mol Psychiatry. 2004 May;9(5):433-41. Review.

PMID:
15037864
3.

Pharmacogenetics and the serotonin transporter in late-life depression.

Gerretsen P, Pollock BG.

Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1465-78. doi: 10.1517/17425250802560279 . Review.

PMID:
19040324
4.

[Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].

Higuchi H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Apr;30(2):71-6. Review. Japanese.

PMID:
20491280
5.

Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatment.

Crawford AA, Lewis G, Lewis SJ, Munafò MR.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1143-50. doi: 10.1016/j.euroneuro.2012.12.001. Review.

6.

Eating disorders, serotonin transporter polymorphisms and potential treatment response.

Gorwood P.

Am J Pharmacogenomics. 2004;4(1):9-17. Review.

PMID:
14987118
7.

Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors.

Lotrich FE, Pollock BG, Ferrell RE.

Am J Pharmacogenomics. 2001;1(3):153-64. Review.

PMID:
12083964
9.

Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis.

Huang CH, Santangelo SL.

Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):903-13. doi: 10.1002/ajmg.b.30720. Review.

PMID:
18286633
10.

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy.

Porcelli S, Fabbri C, Serretti A.

Eur Neuropsychopharmacol. 2012 Apr;22(4):239-58. doi: 10.1016/j.euroneuro.2011.10.003. Review.

PMID:
22137564
11.

Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils.

Rasmussen-Torvik LJ, McAlpine DD.

Depress Anxiety. 2007;24(5):350-7. Review.

PMID:
17096399
12.

Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.

Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, Lerer B, Fava M.

Int Clin Psychopharmacol. 2009 Jan;24(1):19-25. doi: 10.1097/YIC.0b013e328314dfaf. Review.

PMID:
19092448
13.

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy.

Steimer W, Müller B, Leucht S, Kissling W.

Clin Chim Acta. 2001 Jun;308(1-2):33-41. Review.

PMID:
11412815
14.

Association of 5-HTT gene polymorphisms with migraine: a systematic review and meta-analysis.

Liu H, Liu M, Wang Y, Wang XM, Qiu Y, Long JF, Zhang SP.

J Neurol Sci. 2011 Jun 15;305(1-2):57-66. doi: 10.1016/j.jns.2011.03.016. Review.

PMID:
21450309
15.

Genes, stress, and depression.

Wurtman RJ.

Metabolism. 2005 May;54(5 Suppl 1):16-9. Review.

PMID:
15877307
16.

The genetics of selective serotonin reuptake inhibitors.

Kroeze Y, Zhou H, Homberg JR.

Pharmacol Ther. 2012 Dec;136(3):375-400. doi: 10.1016/j.pharmthera.2012.08.015. Review.

PMID:
22944042
17.

The genetics of the serotonin transporter and irritable bowel syndrome.

Colucci R, Blandizzi C, Bellini M, Ghisu N, Tonini M, Del Tacca M.

Trends Mol Med. 2008 Jul;14(7):295-304. doi: 10.1016/j.molmed.2008.05.001. Review.

PMID:
18550438
18.

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.

Kato M, Serretti A.

Mol Psychiatry. 2010 May;15(5):473-500. doi: 10.1038/mp.2008.116. Review.

PMID:
18982004
19.

[Therapy with selective serotonin reuptake inhibitors (SSRI). Indications, uses and risks].

Ebert D.

Fortschr Med. 1996 Jul 1;114(18-19):243-7. Review. German.

PMID:
8766793
20.

Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction.

Brown GW, Harris TO.

J Affect Disord. 2008 Nov;111(1):1-12. doi: 10.1016/j.jad.2008.04.009. Review.

PMID:
18534686
Items per page

Supplemental Content

Support Center